#USA #Leesburg #Haier Biomedical #Resonant Clinical Solutions #LX-60T100R

Innovative Benchtop Centrifuge from Resonant Clinical Solutions and Haier Biomedical

In an exciting collaboration, Resonant Clinical Solutions and Haier Biomedical have announced their newest innovation in the world of clinical research equipment — the LX-60T100R, a benchtop centrifuge engineered with a natural refrigerant. This groundbreaking centrifuge caters specifically to the rigorous demands of clinical trials, marking a significant step ahead of upcoming regulatory changes regarding fluorinated gases in Europe and the United States.

The LX-60T100R is not just another standard centrifuge; it represents a leap towards sustainable laboratory practices. Utilizing hydrocarbon refrigerants, this model drastically reduces environmental impact compared to traditional fluorinated systems. It is designed with user-friendliness in mind while ensuring compliance with forthcoming environmental policies.

Key Features of the LX-60T100R

1. Natural Hydrocarbon Refrigerant: One of the standout features of the new centrifuge is its use of hydrocarbon refrigerant (R290), which significantly minimizes its environmental footprint as opposed to conventional fluorinated gases. These gases have high global warming potential, and transitioning to a natural refrigerant dramatically decreases harmful emissions.

2. Rapid Cooling Capability: This centrifuge can achieve pre-cooling from room temperature to 4 °C in just about five minutes. This quick cooling feature enhances workflow efficiency by reducing the wait times associated with conventional refrigerated centrifuges.

3. Tailored Speed and Rotor Profiles: The LX-60T100R is compatible with standard clinical workflows, accommodating various blood extraction tubes and bottles up to 100 ml, thus meeting the diverse needs of pharmaceutical sponsors and Contract Research Organizations (CROs).

4. Advanced LCD Touchscreen: With a 7-inch LCD touch screen that supports multi-touch control (including functionality with gloves), the centrifuge features user-friendly calibrations, on-screen configurations, and RFID rotor recognition. It supports user access controls and can store over 1,000 programs.

5. Enhanced Safety and Reliability Systems: Equipped with cutting-edge safety mechanisms such as vibration detection, imbalance verification, and lifespan monitoring of rotors, this device promises high reliability. Its low center of gravity also minimizes vibrations during operation.

6. Quiet Operation: Designed to be quiet, this centrifuge operates at noise levels as low as 52 dB(A), making it suitable for shared laboratory spaces and extended procedures without disturbing the work environment.

7. Compact Size: Weighing approximately 46 kg, the LX-60T100R fits comfortably on standard laboratory tables without the need for special anchoring or reinforced surfaces.

8. Significantly Reduced Global Warming Potential: This centrifuge reduces global warming potential (GWP) from over 1,400 in traditional systems to approximately 3, showcasing a remarkable commitment to sustainability without sacrificing cooling performance.

Expert Insights on the Collaboration

Christophe Berthoux, CEO of Resonant Clinical Solutions, expressed, "Our dedication is to provide premier, customer-focused solutions that support the entire lifecycle of complex clinical study programs. Collaborating with Haier Biomedical on this redesigned centrifuge has been crucial in delivering innovative technology that addresses regulatory compliance and market demand while pushing the boundaries of sustainability."

Gang Liu, Co-CEO of Haier Biomedical, added, "Our ability to transform concepts into innovative products in such short timelines demonstrates our commitment to our clients. New challenges in the biomedical sector will continue to emerge, and we remain dedicated to collaborating with scientists to develop solutions that accelerate industry advancements."

Availability and Future Plans

Clinical trial sponsors and CROs can purchase or lease the LX-60T100R exclusively through Resonant until November 2027. The 220-240 V AC model is already available, while a 110 V AC model is scheduled for launch in early 2027. For more information and inquiries, visit resonantclinical.com/products/centrifuges.

In summary, the collaboration between Resonant Clinical Solutions and Haier Biomedical to develop the LX-60T100R benchtop centrifuge not only advances technological capabilities within clinical trials but also sets a considerable standard in sustainability, meeting the urgent environmental needs of the modern laboratory setting. This partnership is poised to transform how clinical research operations are conducted, delivering both efficiency and environmental stewardship.